Assessment of Physical Stability of an Antibody Drug Conjugate by Higher Order Structure Analysis: Impact of Thiol- Maleimide Chemistry

ABSTRACTPurposeTo provide a systematic biophysical approach towards a better understanding of impact of conjugation chemistry on higher order structure and physical stability of an antibody drug conjugate (ADC).MethodsADC was prepared using thiol-maleimide chemistry. Physical stabilities of ADC and its parent IgG1 mAb were compared using calorimetric, spectroscopic and molecular modeling techniques.ResultsADC and mAb respond differently to thermal stress. Both the melting temperatures and heat capacities are substantially lower for the ADC. Spectroscopic experiments show that ADC and mAb have similar secondary and tertiary structures, but these are more easily destabilized by thermal stress on the ADC indicating reduced conformational stability. Molecular modeling calculations suggest a substantial decrease in the conformational energy of the mAb upon conjugation. The local surface around the conjugation sites also becomes more hydrophobic in the ADC, explaining the lower colloidal stability and greater tendency of the ADC to aggregate.ConclusionsComputational and biophysical analyses of an ADC and its parent mAb have provided insights into impact of conjugation on physical stability and pinpointed reasons behind lower structural stability and increased aggregation propensity of the ADC. This knowledge can be used to design appropriate formulations to stabilize the ADC.

[1]  Linda O Narhi,et al.  High throughput thermostability screening of monoclonal antibody formulations. , 2010, Journal of pharmaceutical sciences.

[2]  Joseph McGuire,et al.  Molecular origins of surfactant-mediated stabilization of protein drugs. , 2011, Advanced drug delivery reviews.

[3]  M. Haidekker,et al.  Effects of solvent polarity and solvent viscosity on the fluorescent properties of molecular rotors and related probes. , 2005, Bioorganic chemistry.

[4]  Bernhardt L Trout,et al.  Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding , 2011, mAbs.

[5]  J. Ralston,et al.  Solution Behavior of IFN-β-1a: An Empirical Phase Diagram Based Approach , 2005 .

[6]  Anna M Wu,et al.  Arming antibodies: prospects and challenges for immunoconjugates , 2005, Nature Biotechnology.

[7]  Colleen E. Price,et al.  Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[8]  Aditya A Wakankar,et al.  Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes. , 2010, Bioconjugate chemistry.

[9]  C. Roberts,et al.  Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms. , 2011, Journal of pharmaceutical sciences.

[10]  Mark A Haidekker,et al.  Environment-sensitive behavior of fluorescent molecular rotors , 2010, Journal of biological engineering.

[11]  Bernhardt L Trout,et al.  Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions. , 2011, Journal of pharmaceutical sciences.

[12]  C Russell Middaugh,et al.  Stability of helix-rich proteins at high concentrations. , 2006, Biochemistry.

[13]  Damon L. Meyer,et al.  Contribution of linker stability to the activities of anticancer immunoconjugates. , 2008, Bioconjugate chemistry.

[14]  C Russell Middaugh,et al.  Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. , 2003, Journal of pharmaceutical sciences.

[15]  C E Kung,et al.  Fluorescent molecular rotors: a new class of probes for tubulin structure and assembly. , 1989, Biochemistry.

[16]  Michael M C Sun,et al.  Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides. , 2005, Bioconjugate chemistry.

[17]  K. Kiick,et al.  Tunable degradation of maleimide-thiol adducts in reducing environments. , 2011, Bioconjugate chemistry.

[18]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[19]  Christopher J Roberts,et al.  Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies. , 2010, Journal of pharmaceutical sciences.

[20]  Akihisa Nonoyama,et al.  A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams. , 2008, Journal of pharmaceutical sciences.

[21]  Damon L. Meyer,et al.  Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate , 2004, Clinical Cancer Research.

[22]  M C Manning,et al.  Tyrosine, phenylalanine, and disulfide contributions to the circular dichroism of proteins: circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor. , 1999, Biochemistry.

[23]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[24]  Tim J Kamerzell,et al.  Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability. , 2009, Journal of pharmaceutical sciences.

[25]  M. Lindgren,et al.  Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. , 2005, Biophysical journal.

[26]  Robert A. Grothe,et al.  Structure of the cross-beta spine of amyloid-like fibrils. , 2005, Nature.

[27]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[28]  Boyan Zhang,et al.  Identification of amino acid residues responsible for the release of free drug from an antibody-drug conjugate utilizing lysine-succinimidyl ester chemistry. , 2011, Journal of pharmaceutical sciences.

[29]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[30]  Heather Franey,et al.  Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates , 2010, Protein science : a publication of the Protein Society.

[31]  Bernhardt L Trout,et al.  Computational methods to predict therapeutic protein aggregation. , 2012, Methods in molecular biology.

[32]  Bruce D Mason,et al.  Opalescence of an IgG2 monoclonal antibody solution as it relates to liquid-liquid phase separation. , 2011, Journal of pharmaceutical sciences.

[33]  Aditya A Wakankar,et al.  Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.

[34]  R. Chari Targeted cancer therapy: conferring specificity to cytotoxic drugs. , 2008, Accounts of chemical research.

[35]  David Eisenberg,et al.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.

[36]  Vasco Filipe,et al.  Fluorescent Molecular Rotors as Dyes to Characterize Polysorbate-Containing IgG Formulations , 2009, Pharmaceutical Research.

[37]  S. Joshi,et al.  Investigation of protein conformational stability employing a multimodal spectrometer. , 2011, Analytical chemistry.